Caas Capital Management LP Gilead Sciences, Inc. Call Options Transaction History

Caas Capital Management LP

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $8.81 Million - $11 Million	-152,100 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $136,248 - $154,644	2,100 Added 1.4%	152,100 $11 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $8.43 Million - $9.62 Million	140,500 Added 1478.95%	150,000 $9.7 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $687,230 - $798,000	9,500 New	9,500 $731,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.